The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements

BACKGROUND: Stringent complete response (sCR) is used as a deeper response category than complete response (CR) in multiple myeloma (MM) but may be of limited value in the era of minimal residual disease (MRD) testing. METHODS: Here, we used 4-colour multiparametric flow cytometry (MFC) or next-gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Cedena, Maria-Teresa, Martin-Clavero, Estela, Wong, Sandy, Shah, Nina, Bahri, Natasha, Alonso, Rafael, Barcenas, Carmen, Valeri, Antonio, Salazar Tabares, Johny, Sanchez-Pina, Jose, Cuellar, Clara, Martin, Thomas, Wolf, Jeffrey, Lahuerta, Juan-Jose, Martinez-Lopez, Joaquin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458342/
https://www.ncbi.nlm.nih.gov/pubmed/32866200
http://dx.doi.org/10.1371/journal.pone.0237155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458342/
https://www.ncbi.nlm.nih.gov/pubmed/32866200
http://dx.doi.org/10.1371/journal.pone.0237155

Ejemplares similares